UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043580
Receipt number R000049767
Scientific Title A prospective observational study on the assessment of nutritional status of nursing home users by using a nutritional assessment web form (MNA Plus)
Date of disclosure of the study information 2021/03/18
Last modified on 2023/03/13 10:07:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective observational study on the assessment of nutritional status of nursing home users by using a nutritional assessment web form (MNA Plus)

Acronym

Assessment of nutritional status using the Nutrition Assessment Web Form (MNA Plus)

Scientific Title

A prospective observational study on the assessment of nutritional status of nursing home users by using a nutritional assessment web form (MNA Plus)

Scientific Title:Acronym

Assessment of nutritional status using the Nutrition Assessment Web Form (MNA Plus)

Region

Japan


Condition

Condition

healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Nutritional status will be assessed using Mini Nutritional Assessment (MNA) Plus for elderly people using nursing homes, and changes in weight will be investigated for those who are determined to be undernourished and in need of nutritional supplements.

Basic objectives2

Others

Basic objectives -Others

Others

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Weight change at 3, 6, 9, and 12 months after the start of observation

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Age 65 years or older at the time of consent.
(2) Patients who have been determined by MNA Plus to be in need of an energy boost at the time of eligibility determination and who are undernourished or at risk of undernourishment
(3) Those who fully understand the contents of the study and are able to give consent.

Key exclusion criteria

(1) Patients who are taking nutritional supplements at least once a week at the time of obtaining consent.
(2) Patients who have significant musculoskeletal disorders such as fracture at the time of consent.
(3) Patients who have difficulty in weighing themselves at nursing home.
(4) Patients with severe dementia
(5) Patients who have undergone a surgical operation 4 weeks prior to the start of observation, or who are scheduled to undergo a surgical operation during the observation period
6) Those who are judged by the principal investigator to be inappropriate for this study.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Yukikazu
Middle name
Last name Kamada

Organization

Nestle Health Science Company, Nestle Japan Ltd

Division name

Marketing & Medical Affairs

Zip code

140-0002

Address

2-2-20 Higashi-Shinagawa, Shinagawa-ku, Tokyo

TEL

03-5769-6227

Email

Yukikazu.Kamada@jp.nestle.com


Public contact

Name of contact person

1st name Hiroki
Middle name
Last name Takano

Organization

Nestle Health Science Company, Nestle Japan Ltd

Division name

Marketing & Medical Affairs

Zip code

140-0002

Address

2-2-20 Higashi-Shinagawa, Shinagawa-ku, Tokyo

TEL

03-5769-6227

Homepage URL


Email

Hiroki.Takano@jp.nestle.com


Sponsor or person

Institute

Solasto Corporation

Institute

Department

Personal name



Funding Source

Organization

Nestle Japan Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamauchi Clinic IRB

Address

1-15-19, Jiyugaoka, Meguro Ku, Tokyo To, Japan

Tel

03-5575-5862

Email

c-irb_ug@neues.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 02 Month 26 Day

Date of IRB

2021 Year 03 Month 18 Day

Anticipated trial start date

2021 Year 04 Month 12 Day

Last follow-up date

2022 Year 09 Month 30 Day

Date of closure to data entry

2022 Year 11 Month 30 Day

Date trial data considered complete

2023 Year 01 Month 31 Day

Date analysis concluded



Other

Other related information

nothing


Management information

Registered date

2021 Year 03 Month 10 Day

Last modified on

2023 Year 03 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049767


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name